# Agaviotica S.A. De C.V. · 66-41 · MEXICO — FDA import alert red lists: firms subject to detention without physical examination

For Agaviotica S.A. De C.V. · 66-41 · MEXICO, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is MEXICO; product is Fiber Agave Inulina | Fiber Agave Inulina; product code is 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners | 62 B - - 99 Anti-Hyperlipidemic N.E.C; date published is 10/01/2010; address is Distrito B 4 No 433 , Monterrey, MEXICO, verified against its source on 2026-09-16.

- **Firm:** Agaviotica S.A. De C.V. _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** MEXICO _(verified: appears in the quote below)_
- **Address:** Distrito B 4 No 433 , Monterrey, MEXICO _(verified: appears in the quote below)_
- **Date published:** 10/01/2010 _(verified: appears in the quote below)_
- **Product code:** 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners | 62 B - - 99 Anti-Hyperlipidemic N.E.C. _(verified: each item appears in the quote below)_
- **Product:** Fiber Agave Inulina | Fiber Agave Inulina _(verified: each item appears in the quote below)_
- **FDA notes:** Mexico | Mexico _(verified: each item appears in the quote below)_

## What the source says

> Agaviotica S.A. De C.V. Date Published : 10/01/2010 Distrito B 4 No 433 , Monterrey, MEXICO 41 B - - 99 Foods with Supplemental Nutrients Added, with or without Artifical Sweetners Date Published: 10/01/2010 Desc: Fiber Agave Inulina Notes: Mexico 62 B - - 99 Anti-Hyperlipidemic N.E.C. Date Published: 10/01/2010 Desc: Fiber Agave Inulina Notes: Mexico

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).